A crystal lattice structure, its internal grid exposed at a cut face, as a visual analogue for a coordinate system

Career Timeline

Companies Founded

  • Syntax Data (founded as Locus Analytics, 2009) — Founder and Executive Chairman. Founded the research entity to develop and patent the Locus Model and Functional Information System; Syntax and Locus Analytics merged in March 2023 into the coordinate-based information infrastructure he now leads.
  • Royalty Pharma (1996) — Co-Founder. Started the company with $60 million, building the market for pharmaceutical royalties as an investable asset class; served as Chairman from 2003 until his 2024 resignation.
  • Cibus (NASDAQ: CBUS) — Co-Founder. Later served as Chief Executive Officer from October 2021, applying pharmaceutical-grade production standards to plant biology through the Rapid Trait Development System®, before transitioning to Chairman of the Board in June 2026.
  • Kyntra Bio (formerly known as FibroGen, 1993) — Co-Founder and Director since October 1993, his longest continuously held board seat.
  • SUGEN — Co-Founder and Board Member.
  • BioMatrix (1996) — Founder, serving as President, CFO, and Director through 2000, spanning the Synvisc® launch.
  • Scientia Ventures — Co-Founder and General Partner.

Career Timeline

Executive positions and companies founded or led, in reverse chronological order.

2026–present — Syntax Data, Executive Chairman and Founder

Executive Chairman and Founder of Syntax Data, built on the patented Locus Model and FIS® as a coordinate-based information infrastructure for finance and economic data. Founded as Locus Analytics in 2009; Syntax and Locus Analytics merged in March 2023.

2021–2026 — Cibus, Chief Executive Officer

Co-founder and Chief Executive Officer of Cibus (NASDAQ: CBUS) from October 2021, applying pharmaceutical-grade production standards to plant biology through the Rapid Trait Development System®. Cibus was named Fast Company’s #2 Most Innovative Agriculture Company of 2024.

2017–present — WEBs ETF Trust, CEO and Trustee

CEO and Trustee of the Syntax-affiliated ETF trust since 2017.

Scientia Ventures, General Partner and Co-Founder

General Partner and co-founder of Scientia Ventures.

Balfour Venture Partners, Managing Member

Managing Member of Balfour Venture Partners.

2003–2024 — Royalty Pharma, Chairman

Chairman of the Board through Royalty Pharma’s growth to $26 billion in assets and its 2020 public listing (NASDAQ: RPRX), with partial royalty rights on seven of the top thirty drugs sold in the United States. Resigned as a director in June 2024.

1996 — Royalty Pharma, Co-Founder

Co-founds Royalty Pharma with a $60 million start, building the market for pharmaceutical royalties as an asset class.

1996–2000 — BioMatrix, President, CFO, and Director

President, CFO, and Director of BioMatrix (NYSE: BMX), overseeing the launch of Synvisc®, a viscosupplementation treatment.

1991–1995 — RF&P Corporation, Chief Executive Officer

Chief Executive Officer of RF&P, a real estate investment company owned by the Virginia State Retirement System.

1981–1990 — PaineWebber, Managing Director

Managing Director, Mergers & Acquisitions.

Affiliation History

Current and past board-only roles, where Riggs serves or served as a director but not as an executive officer.

New York Genome Center — Board Member (current)

Director of the New York Genome Center, his primary current nonprofit board.

Feinstein Institute (Northwell Health) — Director (current)

Director of the Feinstein Institute, the research arm of Northwell Health.

Cibus — Chairman of the Board (current)

Transitioned from Chief Executive Officer to Chairman of the Board.

Nucelis Inc. — Chairman (current)

Chairman of Nucelis Inc.

Kyntra Bio (formerly known as FibroGen) — Co-Founder and Director, since 1993

Co-founder and director of Kyntra Bio since October 1993 — his longest confirmed board tenure.

Intra-Cellular Therapies — Director, 2014–2025

Director of Intra-Cellular Therapies (NASDAQ: ITCI) from January 2014, serving on the Audit Committee.

GeneNews / StageZero Life Sciences — Board Chair, since 1998

Board Chair and director of GeneNews, later StageZero Life Sciences, since 1998.

SUGEN Inc. — Co-Founder and Board Member

Co-founder and board member of SUGEN.

Bond Street Marketplace — Angel Investor / Board Member

Angel investor and board member of the fintech company Bond Street Marketplace.

See Credentials for education and recognition, or learn more about the Coordinate System unifying Riggs’s intellectual contributions across these organizations.

Scroll to Top